학술논문
Safety and immunogenicity of the live attenuated intranasal pertussis vaccine BPZE1: a phase 1b, double-blind, randomised, placebo-controlled dose-escalation study
Document Type
Article
Author
Dager, Lena; Ekholm, Nina; Gustafsson, Margareta; Linde, Åsa; Lång, Cecilia; Nastase, Maria; Reinholdsson, Inga-Lill; Sigurdardottir, Erla; Wahlberg, Anneli; Zarea, Izabella; Aktas, Teodora; Andersson, Ingrid; Hanson Pihlainen, Eva; Ljungman, Margaretha; Ringman, Maj; Tecleab, Teghesti; Wehlin, Lena; Allais, Florence; Assuied, Alex; Chêne, Geneviève; Gilbert, Camille; Jean, Delphine; Le Marec, Fabien; Moinot, Laetitia; Reboud, Philippe; Rousseau, Emilie; Roy, Céline; Schwimmer, Christine; Taïeb, Ludivine; Wallet, Cédrick; Derocle, Gabrielle; Gueguen, Sonia; Lévy-Marchal, Claire; Esperou, Hélène; Debrie, Anne-Sophie; Raze, Dominique; Coutte, Loïc; Diallo, Alpha; Mercier, Noémie; Jahnmatz, Maja; Richert, Laura; al-Tawil, Nabil; Storsaeter, Jann; Colin, Céline; Bauduin, Claire; Thalen, Marcel; Solovay, Ken; Rubin, Keith; Mielcarek, Nathalie; Thorstensson, Rigmor; Locht, Camille
Source
In The Lancet Infectious Diseases November 2020 20(11):1290-1301
Subject
Language
ISSN
1473-3099